期刊文献+

西甲硅油对便秘型肠易激综合征患者肠道气体的影响——附28例报告 被引量:6

Effects of simethicone on bowel gas of constipation-dominant irritable bowel syndrome
下载PDF
导出
摘要 目的:探讨西甲硅油对便秘型肠易激综合征(IBS)患者肠道气体的影响。方法:根据罗马Ⅲ诊断标准选取便秘型IBS患者28例,予以口服西甲硅油3ml,3次/日,治疗2周。患者在服药前、后分别摄立位腹部X线平片,用图像处理软件计算气体容积积分(GVS),比较治疗前后GVS值的变化,同时对便秘型IBS患者的腹痛、腹胀症状进行评分并比较。结果:治疗后便秘型IBS患者的GVS为(0.05±0.01),治疗前为(0.08±0.02);治疗后腹痛症状评分为(0.9±0.5)分,治疗前为(2.2±0.6)分;治疗后腹胀症状评分为(0.9±0.6)分,治疗前为(2.0±0.8)分。治疗后便秘型IBS患者的GVS、腹痛症状评分、腹胀症状评分比治疗前明显下降(均为P<0.05)。结论:西甲硅油能减少便秘型IBS患者的肠道气体,有效缓解腹痛、腹胀症状,且安全、有效。 Objective: To study the effects of simethicone on bowel gas of constipation-dominat irritable bowel syndrome (IBS). Methods : The diagnosis of constipation-dominant IBS was based on Rome III diagnostic criteria, and 28 patients with constipation-dominant IBS were enrolled. Each subject received simethicone 3ml, po, three times daily for two weeks. Plain abdominal radiographs were obtained before and after treatment to calculate the gas volume score (GVS) for comparison. The degree of abdominal pain and abdominal distention were evaluated and scored. Results: The mean GVS, score of abdominal pain and score of abdominal distention significantly decreased after treatment(P 〈0. 05). Conclusion: Simethicone can reduce bowel gas in constipation-dominant IBS and release abdominal pain and abdominal distension safely and effectively.
出处 《新医学》 2010年第1期16-17,20,共3页 Journal of New Medicine
基金 浙江温州市科技局课题(Y20060141)
关键词 西甲硅油 肠易激综合征 便秘型 肠道气体 腹痛 腹胀 Simethicone Irritable bowel syndrome, Constipation-dominant Bowel gas Abdominal pain Abdominal distension
  • 相关文献

参考文献9

二级参考文献58

  • 1王如涛,周惠清,宋光辉,刘清华,许小幸,李定国,陆汉明.罗马Ⅱ标准在肠易激综合征诊断中的价值[J].胃肠病学,2004,9(4):227-229. 被引量:10
  • 2李定国,刘栋,许小幸,陆汉明.青少年儿童肠易激综合征的流行病学调查[J].中华消化杂志,2005,25(5):266-269. 被引量:51
  • 3Eamonn MM Quigley.Changing face of irritable bowel syndrome[J].World Journal of Gastroenterology,2006,12(1):1-5. 被引量:6
  • 4LONGSTRETH G F, THOMPSON W G, CHEY W D, et al. Functional bowel disorders [ J ] . Gastroenterology, 2006, 130 (5): 1480-1491.
  • 5VANDVIK P O, AABAKKEN L, FARUP P G. Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome Ⅱ criteria[ J]. Scand J Gastroenterol, 2004, 39 (5): 448-453.
  • 6[1]Lauer GM,Walker BD.Hepatitis C virus infection.N Engl J Med 2001; 345:41-52.
  • 7[2]Alter MJ,Kruszon-Moran D,Nainan OV,McQuillan GM,Gao F,Moyer LA,Kaslow RA,Margolis HS.The prevalence of hepatitis C virus infection in the United States,1988 through 1994.N Engl J Med 1999; 341:556-562
  • 8[3]Curry MP.Hepatitis B and hepatitis C viruses in liver transplantation.Transplantation 2004; 78:955-963
  • 9[4]Vargas HE,Laskus T,Radkowski M,Wilkinson J,Balan V,Douglas DD,Harrison ME,Mulligan DC,Olden K,Adair D,Rakela J.Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation.Liver Transpl 2002; 8:1014-1019
  • 10[5]Yan FM,Chen AS,Hao F,Zhao XP,Gu CH,Zhao LB,Yang DL,Hao LJ.Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C.World J Gastroenterol 2000; 6:805-811

共引文献331

同被引文献94

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部